Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2007-12-19
2009-10-06
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001690, C424S001810, C424S001850, C424S009400, C424S009411, C424S009420
Reexamination Certificate
active
07597876
ABSTRACT:
The present application discloses compositions and methods of synthesis and use of F-18 labeled molecules of use, for example, in PET imaging techniques. In particular embodiments, the labeled molecules may be peptides or proteins, although other types of molecules including but not limited to aptamers, oligonucleotides and nucleic acids may be labeled and utilized for such imaging studies. In preferred embodiments, the F-18 label may be conjugated to a targeting molecule by formation of a metal complex and binding of the F-18-metal complex to a chelating moiety, such as DOTA, NOTA, DTPA, TETA or NETA. In other embodiments, the metal may first be conjugated to the chelating group and subsequently the F-18 bound to the metal. In other preferred embodiments, the F-18 labeled moiety may comprise a targetable conjugate that may be used in combination with a bispecific or multispecific antibody to target the F-18 to an antigen expressed on a cell or tissue associated with a disease, medical condition, or pathogen. Exemplary results show that F-18 labeled targetable conjugate peptides are stable in human serum at 37° C. for several hours, sufficient time to perform PET imaging analysis.
REFERENCES:
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5446147 (1995-08-01), Kung et al.
patent: 6019957 (2000-02-01), Miller et al.
patent: 6056939 (2000-05-01), Desreux et al.
patent: 6207858 (2001-03-01), Chinn et al.
patent: 6605615 (2003-08-01), Medina et al.
patent: 6838073 (2005-01-01), Collins et al.
patent: 6953567 (2005-10-01), Griffiths
patent: 7011816 (2006-03-01), Griffiths et al.
patent: 2005/0136001 (2005-06-01), McBride et al.
patent: 2006/0140858 (2006-06-01), Goldenberg et al.
patent: 2008/0253964 (2008-10-01), McBride et al.
patent: 2007027385 (2007-03-01), None
patent: 2008088648 (2008-07-01), None
Imahori et al. “Fluorine-18-Labeled Fluoroboronophenylalanine PET in Patients with Glioma” J Nucl Med 1998; 39:325-333.
McBride et al. “A new method of labeling peptides and proteins with F-18 via a metal ligand” Abstract #384, J Nucl Med. 2008; 49 (Supplement 1):97P.
McBride et al. “A new method of labeling peptides and proteins with F-18 via a metal ligand”, PowerPoint Presentation, 55th SNM Annual Meeting, New Orleans, LA, Jun. 17, 2008.
McBride et al. “A New Method of Labeling Peptides with F-18 Via a Metal Ligand”, Abstract #04, Cancer Biother Radiopharm Aug. 2008; 23(4): 514.
McBride et al. “A New Method of Labeling Peptides with F-18 Via a Metal Ligand” Abstract #68, 19th Winter Fluorine Conference (Jan. 11-16, 2009) Abstract Book, p. 32.
McBride et al. “A New Method of Labeling Peptides with F-18 Via a Metal Ligand” PowerPoint Presentation, 19th Winter Fluorine Conference, St. Pete Beach, FL, Jan. 13, 2009.
Wagner, Henry N. “Advancing a Molecular Theory of Disease”, J Nulc Med 49(8):15N-34N. (2008).
International Patent Appl. No. PCT/US08/62108 titled “Improved Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules” filed Apr. 30, 2008.
U.S. Appl. No. 12/343,655 titled “Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules” filed Dec. 24, 2008.
Cai et al. “Chemistry with [18F]Fluoride Ion” Eur. J. Org. Chem. 2008, pp. 2853-2873.
Mamat et al., “Recent Applications of Click Chemistry for the Synthesis of Radiotracers for Molecular Imaging” Mini-Reviews in Organic Chemistry, 2009, vol. 6, pp. 21-34.
Marik et al. “Click for PET: rapid preparation of [18F]fluoropeptides using Cul catalyzed 1,3-dipolar cycloaddition” Tetrahedron Letters 47 (2006) 6681-6684.
Miller et al. “Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography” Angew. Chem. Int. Ed. 2008, vol. 47, pp. 8998-9033.
Schirrmacher et al. “Recent Developments and Trends in 18F-Radiochemistry: Syntheses and Applications” Mini-Reveiws in Organic Chemistry, 2007, vol. 4, pp. 317-329.
Ting et al. “Toward [18F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice” J. Am. Chem. Soc. 2008, vol. 130, pp. 12045-12055.
Ting et al. “Arylfruoroborates and Alkylfluorosilicates as Potential PET Imaging Agents: High-Yielding Aqueous Biomolecular 18F-Labeling” J. Am. Chem. Soc. 2005, vol. 127, pp. 13094-13095.
Karacay et al. “18F labeling of a peptide for PET imaging of receptor-expressing tumors” Abstract # 1567, 2009 SNM Annual Meeting Scientific Abstracts 50(Suppl. 2), p. 318P, May 2009.
McBride et al. “A novel method of radiolabeling peptides with aluminium-fluoride-18 (AIF-18) using various NOTA derivatives” Abstract # 202, 2009 SNM Annual Meeting Scientific Abstracts 50(Suppl. 2), pp. 52P-53P, May 2009.
Schoffelen et al. “Pretargeted immunoPET for imaging colorectal cancer in a mouse model” Abstract # 381, 2009 NM Annual Meeting Scientific Abstracts 50(Suppl. 2), pp. 100P, May 2009.
Wester et al. “Fluorine-18 Labeling of Peptides and Proteins”, Review, Ernst Schering Res. Found. Workshop 62:79-111(2007).
Goldenberg David M.
McBride William J.
Immunomedics Inc.
Jones D L
Nakashima Richard A.
LandOfFree
Methods and compositions for improved F-18 labeling of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for improved F-18 labeling of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for improved F-18 labeling of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4118519